Trial intelligence / Profile preview

Methylphenidate Effects on Academic Activity in ADHD

NCT02501798Phase 4Completed

Sponsor
Vrije Universiteit Amsterdam
Start
Jan 2013
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate with Placebo (2 arms). Primary endpoints: Mathematical performance at 3.5 years, Reading performance at 3.5 years and 1 more. Started Jan 2013; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT02501798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02501798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call